Exploring treatment for CSA: controversies and potential strategies

Winfried Randerath, MD, FCCP, Centre of Sleep Medicine and Respiratory Care, Bethanien Hospital, University of Cologne, Solingen, Germany, discusses the ongoing controversy surrounding the treatment of central sleep apnea (CSA). He emphasizes that observational studies indicate poorer outcomes for patients with CSA compared to those without breathing disturbances. Prof. Randerath highlights various treatment approaches, including continuous positive airway pressure (CPAP) and adaptive servo-ventilation. This interview took place at the Sleep Europe 2024 congress in Seville, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.